Sichenzia Ross Ference Kesner LLP代表PolarityTE，Inc.以3740万美元公开发售
Press Release – New York, NY – April 16, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented PolarityTE, Inc. (“NASDAQ. COOL”) in a $37.4 million public offering of common stock. A total of 2,335,937 shares of common stock were sold at a price of $16.00 per share, which includes shares sold upon exercise of the underwriters’ over-allotment option. Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering. PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products for the fields of medicine, biomedical engineering and material sciences. The Sichenzia Ross Ference Kesner LLP team was led by Partners Harvey Kesner and Tara Guarneri-Ferrara and associate Evan Berger.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- 加州新商业融资披露立法 - September 28, 2018
- Sichenzia Ross Ference LLP宣布推出新的Web域名 - September 26, 2018
- Sichenzia Ross Ference LLP Represents AIT Therapeutics, Inc. in $20,000,000 Line of Credit - September 6, 2018